[HTML][HTML] Pharmacotherapy for non-alcoholic fatty liver disease: emerging targets and drug candidates
VA Prikhodko, NN Bezborodkina, SV Okovityi - Biomedicines, 2022 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD), or metabolic (dysfunction)-associated fatty liver
disease (MAFLD), is characterized by high global incidence and prevalence, a tight …
disease (MAFLD), is characterized by high global incidence and prevalence, a tight …
[PDF][PDF] Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates. Biomedicines 2022, 10, 274
VA Prikhodko, NN Bezborodkina, SV Okovityi - 2022 - researchgate.net
Non-alcoholic fatty liver disease (NAFLD), or metabolic (dysfunction)-associated fatty liver
disease (MAFLD), is characterized by high global incidence and prevalence, a tight …
disease (MAFLD), is characterized by high global incidence and prevalence, a tight …
Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates.
VA Prikhodko, NN Bezborodkina, SV Okovityi - Biomedicines, 2022 - europepmc.org
Non-alcoholic fatty liver disease (NAFLD), or metabolic (dysfunction)-associated fatty liver
disease (MAFLD), is characterized by high global incidence and prevalence, a tight …
disease (MAFLD), is characterized by high global incidence and prevalence, a tight …
[PDF][PDF] Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates. Biomedicines 2022, 10, 274
VA Prikhodko, NN Bezborodkina, SV Okovityi - 2022 - academia.edu
Non-alcoholic fatty liver disease (NAFLD), or metabolic (dysfunction)-associated fatty liver
disease (MAFLD), is characterized by high global incidence and prevalence, a tight …
disease (MAFLD), is characterized by high global incidence and prevalence, a tight …
[PDF][PDF] Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates. Biomedicines 2022, 10, 274
VA Prikhodko, NN Bezborodkina, SV Okovityi - 2022 - sochob.cl
Non-alcoholic fatty liver disease (NAFLD), or metabolic (dysfunction)-associated fatty liver
disease (MAFLD), is characterized by high global incidence and prevalence, a tight …
disease (MAFLD), is characterized by high global incidence and prevalence, a tight …
Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates.
VA Prikhodko, NN Bezborodkina… - Biomedicines, 2022 - search.ebscohost.com
Non-alcoholic fatty liver disease (NAFLD), or metabolic (dysfunction)-associated fatty liver
disease (MAFLD), is characterized by high global incidence and prevalence, a tight …
disease (MAFLD), is characterized by high global incidence and prevalence, a tight …
Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates
VA Prikhodko, NN Bezborodkina, SV Okovityi - Biomedicines, 2022 - search.proquest.com
Non-alcoholic fatty liver disease (NAFLD), or metabolic (dysfunction)-associated fatty liver
disease (MAFLD), is characterized by high global incidence and prevalence, a tight …
disease (MAFLD), is characterized by high global incidence and prevalence, a tight …
[引用][C] Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates
VA Prikhodko, SV Okovityi, NN Bezborodkina - Biomedicines, 2022 - elibrary.ru
Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates
VA Prikhodko, NN Bezborodkina, SV Okovityi - 2022 - agris.fao.org
Non-alcoholic fatty liver disease (NAFLD), or metabolic (dysfunction)-associated fatty liver
disease (MAFLD), is characterized by high global incidence and prevalence, a tight …
disease (MAFLD), is characterized by high global incidence and prevalence, a tight …
Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates
VA Prikhodko, NN Bezborodkina… - Biomedicines, 2022 - pubmed.ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD), or metabolic (dysfunction)-associated fatty liver
disease (MAFLD), is characterized by high global incidence and prevalence, a tight …
disease (MAFLD), is characterized by high global incidence and prevalence, a tight …